Integral Diagnostics, a leading provider of diagnostic imaging services, is headquartered in Australia and operates extensively across major regions including Queensland, Victoria, and Western Australia. Founded in 2006, the company has established itself as a key player in the healthcare sector, focusing on high-quality radiology services. Specialising in a range of imaging modalities such as MRI, CT, and ultrasound, Integral Diagnostics is recognised for its commitment to advanced technology and patient care. The company’s unique approach combines state-of-the-art equipment with a team of highly skilled professionals, ensuring accurate and timely diagnoses. With a strong market position, Integral Diagnostics has achieved significant milestones, including numerous accreditations and partnerships that enhance its service offerings. As a trusted name in the industry, Integral Diagnostics continues to set benchmarks for excellence in diagnostic imaging.
How does Integral Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Integral Diagnostics's score of 21 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2025, Integral Diagnostics reported total carbon emissions of approximately 32,746,000 kg CO2e, with Scope 1 emissions at about 645,000 kg CO2e, Scope 2 emissions (market-based) at approximately 12,993,000 kg CO2e, and Scope 3 emissions reaching about 18,492,000 kg CO2e. For the previous year, 2024, the company recorded total emissions of about 32,174,000 kg CO2e, with Scope 1 emissions at 470,000 kg CO2e, Scope 2 emissions (market-based) at approximately 8,126,000 kg CO2e, and Scope 3 emissions at about 17,720,000 kg CO2e. Integral Diagnostics has not set specific reduction targets or initiatives as part of their climate commitments, and there are no data cascaded from a parent company. The organisation's emissions data is independently reported, reflecting their commitment to transparency in environmental impact. The company continues to monitor and report its emissions, contributing to the broader industry efforts in addressing climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | 432,700 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 6,716,500 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Integral Diagnostics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

